Skip to main content

Table 2 Univariate analysis of clinical and epidemiological factors and TC/HDL ratio

From: Dyslipidaemia in HIV-infected women on antiretroviral therapy. Analysis of 922 patients from the Spanish VACH cohort

 

n

TC/HDL ratio (mean ± SD)

p

Previous AIDS

   

Yes

230

3.85 ± 1.12

0.165

No

677

3.71 ± 1.11

 

HIV-1 viral load

   

Detectable

131

3.89 ± 1.20

0.099

Undetectable

776

3.72 ± 1.10

 

Hypertension

   

Yes

149

3.87 ± 1.26

0.156

No

758

3.72 ± 1.09

 

Previous CVD

   

Yes

13

3.76 ± 1.42

0.958

No

894

3.74 ± 1.12

 

Diabetes

   

Yes

23

4.43 ± 1.59

0.003

No

894

3.73 ± 1.10

 

Type of smoker

   

Current smoker

496

3.79 ± 1.18

0.193

Ex-smoker

61

3.88 ± 1.36

 

Never smoker

350

3.67 ± 0.97

 

T-NRTI treatment

   

Yes

178

3.68 ± 1.03

0.414

No

729

3.76 ± 1.13

 

PI treatment

   

Yes

417

3.94 ± 1.23

<0.001

No

490

3.58 ± 0.98

 

NNRTI treatment

   

Yes

440

3.58 ± 0.97

<0.001

No

467

3.91 ± 1.23

 

HBV coinfection

   

Positive

31

3.88 ± 1.25

0.462

Negative

728

3.73 ± 1.11

 

HCV coinfection

   

Positive

360

3.63 ± 1.15

0.034

Negative

438

3.80 ± 1.08

 
  1. SD: Standard deviation; AIDS: Acquired immune deficiency syndrome; Previous CVD: previous history of cardiovascular disease: T-NRTI: Thymidine NRTI (AZT or d4T); PI: protease inhibitor; NNRTI: non-nucleoside reverse transcriptase inhibitor; HBV: hepatitis B virus; HCV: hepatitis C virus.